Ergomed Clinical Research

Overview

Ergomed Clinical Research is a Contract Research Organization specializing in oncology, rare disease, and complex clinical trials. With over 25 years of experience and a deep bench of more than 100 MDs and PhDs, the organization combines scientific expertise with patient-centric approaches to accelerate drug development and approval.

Core Capabilities

Therapeutic Expertise: Ergomed excels in complex clinical trial design and execution, particularly for novel treatment modalities including cell and gene therapies, oncolytic viruses, biologics, and personalized medicines. The organization has demonstrated expertise in managing trials involving vulnerable populations, including children and those with rare diseases.

Global Reach: With a presence in over 100 countries, Ergomed provides true global clinical trial delivery. Senior leadership and operational hubs are located in Raleigh and Boston, combining global scale with a strong U.S. footprint to support clinical development across North America and beyond.

Patient-Centric Approach: Rooted in the organization's origins as practicing physicians, Ergomed actively collaborates with advocacy groups, caregivers, and trusted physicians to understand the patient journey and expedite delivery of life-changing medicines.

Regulatory & Scientific Strengths

The organization leverages deep understanding of regulatory landscapes, cutting-edge technology, and data-driven methodologies to deliver customized solutions that navigate complex regulatory requirements and operational challenges across diverse regions.